Compounds of formula 1 modulate the activity of Rho C: ##STR1## wherein n is 2 to 5, inclusive; R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, and R.sub.9 are each independently H, halo, lower alkyl, lower alkoxy, lower alkylamino, trifluoromethyl, nitro, lower alkylthio, or two adjacent residues form cycloalkyl, cycloalkenyl, aryl, or lower alkylenedioxy; and pharmaceutically acceptable salts thereof.

Os compostos da fórmula 1 modulam a atividade do ró C: ## do ## STR1 wherein n é 2 a 5, inclusivo; R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, e R.sub.9 são cada um independentemente H, halo, um alkyl mais baixo, um alkylamino alkoxy, mais baixo mais baixo, trifluoromethyl, alkylthio nitro, mais baixo, ou dois resíduos adjacentes dão forma ao cycloalkyl, cycloalkenyl, arilo, ou abaixam o alkylenedioxy; e pharmaceutically sais aceitáveis disso.

 
Web www.patentalert.com

< Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives

< Guanidinylation, guanidinoglycosides, uses, and methods of assaying their activity

> Growth hormone secretagogues

> Synthetic endogenous cannabinoids analogues and uses thereof

~ 00089